Literature DB >> 619151

Thiazolinone analogues of indolmycin with antiviral and antibacterial activity.

M R Harnden, S Bailey, M R Boyd, D R Taylor, N D Wright.   

Abstract

Total synthesis of a series of thiazolinone and thiazolidinone analogues of the antibacterial oxazolinone antibiotic indolmycin is described. The synthetic route involves nucleophilic displacement of mesyloxy and chloro groups from methyl 2-substituted-3-(indol-3-yl)propionates 3 and 4 and butyrate 19 with N-substituted thioureas. The formation of the rearranged chloro esters 29, 43, and 44 from beta(RS,RS)-methyl indolmycenate (27), alpha(RS,SR)-methyl 2-hydroxy-3-(2-methylindol-3-yl)butyrate (39), and alpha-methyl 2-hydroxy-3-(indol-3-yl)valerate (41) supports a reaction mechanism involving neighboring group participation by the indole C-3 carbon during nucleophilic displacement on the beta-carbon of a C-3 substituent. Structure-activity relationships are discussed. Although neither indolmycin nor its diastereoisomer isoindolmycin is antiviral, 2-monoalkylaminothiazolinone analogues have in vitro activity against both RNA viruses and bacteria. The most active compound is the sulfur isostere of indolmycin, and only the levorotatory enantiomer 46, with the same absolute stereochemistry as natural indolmycin, has antimicrobial activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 619151     DOI: 10.1021/jm00199a015

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  (E)-4-(2,3-Dihydro-1,3-benzothia-zol-2-yl-idene)-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one.

Authors:  Imane Chakibe; Abdelfettah Zerzouf; El Mokhtar Essassi; Martin Reichelt; Hans Reuter
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-04-17

2.  Experimental and theoretical studies on the functionalization reactions of 4-benzoyl-1,5-diphenyl-1H-pyrazole-3-carboxylic acid and acid chloride with 2,3-diaminopyridine.

Authors:  Ismail Yildirim; Fatma Kandemirli; Elif Demir
Journal:  Molecules       Date:  2005-03-31       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.